Where does C.C. Imex rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), C.C. Imex ranks #39,360 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does C.C. Imex hold?

C.C. Imex holds 6 US utility patents granted between 2015 and 2025, spanning 3 technology areas.

What is C.C. Imex's Innovation Score?

C.C. Imex has an Innovation Score of 37.5 out of 100 (top 43% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is C.C. Imex's patent grant rate increasing or decreasing?

C.C. Imex's recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for C.C. Imex's patents?

C.C. Imex's patents average 18.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the C.C. Imex patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

C.C. Imex

Q: What technology areas does C.C. Imex focus on?

C.C. Imex's top technology area is C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters) with 3 patents, ranking #275 of 832 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Ferme).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, C.c. ranks #39,360 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 3 technology areas.

#39,360
of 49,997 US assignees by volume: Top 43%
by Innovation Score (37.5/100): 18.8
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R39360 · US Corporation #39,360 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #39,360/49,997
PHOTO-FINISH C Laser
CPC-NARROW C12M · 3 areas
INNOV-THIN 37.5/100
CLAIMS-RICH 18.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: C Laser, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How C.c.’s 37.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (18%) Velocity 13.3 pts (36%) Breadth 6.1 pts (16%) Claim depth 11.3 pts (30%)

Qualcomm Incorporated · highest

85
C C Imex · this assignee

37
Eyelock · near

37
Reeves Wireline · near

37
Jiangsu Hengli… · near

37
Lycera · near

37
3D Lighting… · lowest

7

What this shows C.c.'s Innovation Score is 37.5/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for C.c.?

Each dot is one of C.c.’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). C.c.’s own 18.8 claims/patent is ABOVE the 9.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

C.c. vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where C.c.'s grants concentrate

C.C. Imex is a focused PatentsView assignee: 3 CPC subclasses with 50% of grants classified under C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Ferme). Peak complete grant year is 2024 (2 grants) versus a trough of 1 in 2015. By volume, C.c. sits between C Laser, Inc. and C4X Discovery Limited.

C.c.'s three-year grant acceleration

C.C. Imex shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

C Laser

6
C&C International

6
C&M Baling Systems

6
C&U

6
C C P Contact Pro…

6
C G AIR SYSTÈMES

6
C R D Centro Rice…

6
C4X Discovery

6
C C Imex ◀

6

What this shows C.C. holds 6 patents at rank #39,286, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near CC

By rank, the assignees closest to #39,286 in granted patent volume.

Leaders in C12M (Apparatus FOR Enzymology OR Microbiology)

Other assignees with the most granted patents in CC's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for CC, neither rank-band nor same-CPC leaders (those blocks stay above). In C12M (Apparatus FOR Enzymology OR Microbiology), CC ranks #275 of 832 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (37 here).

Reeves Wireline Technologies Limited 37 Eyelock LLC 37 Jiangsu Hengli Chemical Fibre Co., Ltd. 37 Lycera Corporation 37

C.c.'s Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 43% higher than 57% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

C.C. Imex patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	16.7%
2017	1	16.7%
2020	1	16.7%
2024	2	33.3%
2025partial year	1	16.7%

Which technologies does C.C. Imex patent most?

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

C.C. Imex's patent record in context - here's where to go next.

C.C. Imex's lead technology class is C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Ferme), 50% of its portfolio - see every assignee active in that class. Explore C12M
Ranked #39,360 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare C.C. Imex against C Laser, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.